Status:
COMPLETED
Febrile Illness in Kinshasa and Kimpese
Lead Sponsor:
Institute of Tropical Medicine, Belgium
Collaborating Sponsors:
Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo
Conditions:
Febrile Illness
Eligibility:
All Genders
2+ years
Brief Summary
This is a bi-centric prospective observational cohort study of adults and children presenting to the emergency room or outpatient department with community febrile illness (with or without signs of fo...
Eligibility Criteria
Inclusion
- Ongoing and objectified fever at presentation, or documented at home or other health center within 24 hours prior to presentation, defined by:
- Axillary or tympanic temperature \> 37.5°C OR
- Oral or rectal temperature \> 38°C
- Possibility of contact between the patient (or designated relative) and the study team on days 7, 14 and 21
- Informed consent signed by the patient (adults) or a legally acceptable representative (children or patients whose condition does not allow them to sign informed consent), with the consent of children as young as 12 years of age, whenever possible.
Exclusion
- Children less than two months old
- Hospitalization \> 48 h in the last 14 days (to exclude nosocomial fevers)
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 18 2023
Estimated Enrollment :
1046 Patients enrolled
Trial Details
Trial ID
NCT04760678
Start Date
March 1 2021
End Date
September 18 2023
Last Update
March 6 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
IME Kimpese
Kimpese, Bas-Congo Province, Democratic Republic of the Congo
2
Hôpital General de Kinshasa
Kinshasa, Democratic Republic of the Congo